Author: Scott Welch

America’s prescription-drug prices are out of control. The problem is so large that it has begun attracting high-profile new market entrants, like the Mark Cuban Cost Plus Drug Company that launched earlier this year. Cuban seeks to fix the convoluted prescription-drug market by not taking insurance, and charging 15% over cost. But another path exists for health ...

Employer health startup Transcarent is making its next move with the launch of its new pharmacy program. Transcarent’s Pharmacy Care offering is designed to be fully transparent and integrate with its other platforms. The goal, executives said, is to break through the noise for members and make it easier for them to understand their pharmacy ...

Big tech and retail giants like Amazon and Walmart joined hundreds of provider groups, hospitals and virtual care companies pressing Congress to take action on telehealth legislation this fall. More than 370 organizations sent a joint letter (PDF) to bipartisan leadership of the U.S. Senate to pass a two-year extension of important telehealth policies enacted at the start ...

Consumers are bombarded with misleading advertising for Medicare Advantage and other health plans. Insurance regulators are taking action to identify and combat the improper marketing of these health plans.

The Inflation Reduction Act is set to lower drug prices for millions of people in the U.S. — but experts fear pharmaceutical companies could exploit loopholes in the bill, ultimately keeping prescription costs high for many. The law takes aim at insulin costs, caps out-of-pocket spending for Medicare beneficiaries, and allows the federal government to ...

With current COVID-19 Supplemental Paid Sick Leave (SPSL) requirements set to expire on September 30, the California Legislature has passed California Assembly Bill 152 (AB 152), which now awaits Governor Gavin Newsom’s signature.

Businesses continue to struggle with ever-rising healthcare costs with 7 in 10 employers expecting moderate to significant increases in what they pay for healthcare benefits over the next three years.

Two weeks after the CDC and FDA authorized Moderna's bivalent omicron booster for emergency use, doses are running out in a few U.S. states.

With 400 to 500 Americans still dying every day of Covid-19, President Biden has declared that “the pandemic is over.”

Have you been wondering whether long COVID was a true post-virus symptom? Now it has been officially confirmed – because researchers have put a price tag on what its costing employer sponsored health plans.